BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 30741938)

  • 21. Ameloblastoma: A Review of Recent Molecular Pathogenetic Discoveries.
    Brown NA; Betz BL
    Biomark Cancer; 2015; 7(Suppl 2):19-24. PubMed ID: 26483612
    [TBL] [Abstract][Full Text] [Related]  

  • 22. HRAS as a potential therapeutic target of salirasib RAS inhibitor in bladder cancer.
    Sugita S; Enokida H; Yoshino H; Miyamoto K; Yonemori M; Sakaguchi T; Osako Y; Nakagawa M
    Int J Oncol; 2018 Aug; 53(2):725-736. PubMed ID: 29901113
    [TBL] [Abstract][Full Text] [Related]  

  • 23. IQGAP1 is an oncogenic target in canine melanoma.
    Lee BH; Neela PH; Kent MS; Zehnder AM
    PLoS One; 2017; 12(4):e0176370. PubMed ID: 28445541
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The RAS/MAPK syndromes: novel roles of the RAS pathway in human genetic disorders.
    Aoki Y; Niihori T; Narumi Y; Kure S; Matsubara Y
    Hum Mutat; 2008 Aug; 29(8):992-1006. PubMed ID: 18470943
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Porocarcinomas harbor recurrent HRAS-activating mutations and tumor suppressor inactivating mutations.
    Harms PW; Hovelson DH; Cani AK; Omata K; Haller MJ; Wang ML; Arps D; Patel RM; Fullen DR; Wang M; Siddiqui J; Andea A; Tomlins SA
    Hum Pathol; 2016 May; 51():25-31. PubMed ID: 27067779
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Computed tomographic characteristics of odontogenic neoplasms in dogs.
    Amory JT; Reetz JA; Sánchez MD; Bradley CW; Lewis JR; Reiter AM; Mai W
    Vet Radiol Ultrasound; 2014; 55(2):147-58. PubMed ID: 24102949
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunohistochemical detection of phosphorylated JNK, p38 MAPK, and ERK5 in ameloblastic tumors.
    Kumamoto H; Ooya K
    J Oral Pathol Med; 2007 Oct; 36(9):543-9. PubMed ID: 17850438
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression of astrocyte elevated gene-1 protein in ameloblastomas, keratocystic odontogenic tumors, and dentigerous cysts.
    Wu YH; Chang JY; Tseng CH; Chiang CP; Wang YP
    J Oral Pathol Med; 2017 Feb; 46(2):121-126. PubMed ID: 27381451
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Canine acanthomatous epulis. The only common spontaneous ameloblastoma in animals.
    Gardner DG
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 1995 May; 79(5):612-5. PubMed ID: 7600226
    [TBL] [Abstract][Full Text] [Related]  

  • 30. ERK-TSC2 signalling in constitutively-active HRAS mutant HNSCC cells promotes resistance to PI3K inhibition.
    Ruicci KM; Pinto N; Khan MI; Yoo J; Fung K; MacNeil D; Mymryk JS; Barrett JW; Nichols AC
    Oral Oncol; 2018 Sep; 84():95-103. PubMed ID: 30115483
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cooperation of BRAF(F595L) and mutant HRAS in histiocytic sarcoma provides new insights into oncogenic BRAF signaling.
    Kordes M; Röring M; Heining C; Braun S; Hutter B; Richter D; Geörg C; Scholl C; Gröschel S; Roth W; Rosenwald A; Geissinger E; von Kalle C; Jäger D; Brors B; Weichert W; Grüllich C; Glimm H; Brummer T; Fröhling S
    Leukemia; 2016 Apr; 30(4):937-46. PubMed ID: 26582644
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Detection of mitochondria-mediated apoptosis signaling molecules in ameloblastomas.
    Kumamoto H; Ooya K
    J Oral Pathol Med; 2005 Oct; 34(9):565-72. PubMed ID: 16138896
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunohistochemical detection of hepatocyte growth factor, transforming growth factor-beta and their receptors in epithelial odontogenic tumors.
    Kumamoto H; Yoshida M; Ooya K
    J Oral Pathol Med; 2002 Oct; 31(9):539-48. PubMed ID: 12269993
    [TBL] [Abstract][Full Text] [Related]  

  • 34. RAS/PI3K crosstalk and cetuximab resistance in head and neck squamous cell carcinoma.
    Rampias T; Giagini A; Siolos S; Matsuzaki H; Sasaki C; Scorilas A; Psyrri A
    Clin Cancer Res; 2014 Jun; 20(11):2933-46. PubMed ID: 24696319
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Assessing pathogenic mutations in dental follicles as an attempt to identify early events in odontogenic tumours tumourigenesis.
    Coura BP; de Resende TAC; de Menezes VCB; Bernardes VF; de Sousa SF; Diniz MG; Gomez RS; Gomes CC
    Arch Oral Biol; 2020 May; 113():104523. PubMed ID: 31543246
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mutational Signatures in Mandibular Ameloblastoma Correlate with Smoking.
    Guan P; Wong SF; Lim JQ; Ng CCY; Soong PL; Sim CQX; Ong CK; Rajasegaran V; Myint SS; Lee JY; Tan HK; Iyer NG; Soo KC; Teh BT; Tay ABG
    J Dent Res; 2019 Jun; 98(6):652-658. PubMed ID: 30917298
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Suspected Lateral Periodontal Cyst Presenting Concurrently with Canine Acanthomatous Ameloblastoma in a 2-Year-Old Standard Poodle.
    Tjepkema J; Soukup JW; Bell C
    J Vet Dent; 2017 Sep; 34(3):141-147. PubMed ID: 28639881
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The relationship of the canine acanthomatous epulis to ameloblastoma.
    Gardner DG; Baker DC
    J Comp Pathol; 1993 Jan; 108(1):47-55. PubMed ID: 8473558
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression of p21RAS in odontogenic tumors.
    Sandros J; Heikinheimo K; Happonen RP; Stenman G
    APMIS; 1991 Jan; 99(1):15-20. PubMed ID: 1704240
    [TBL] [Abstract][Full Text] [Related]  

  • 40. PIK3CA, HRAS and KRAS gene mutations in human penile cancer.
    Andersson P; Kolaric A; Windahl T; Kirrander P; Söderkvist P; Karlsson MG
    J Urol; 2008 May; 179(5):2030-4. PubMed ID: 18355852
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.